Metastatic iris tumor.
Onda M, Makino S.
QJM. 2023 Sep 12;116(8):694-695. doi: 10.1093/qjmed/hcad071.
[Clinico-echographic diagnostics of iris tumors].
Koch KR, Mor JM, Avgitidou G, Kakkassery V, Rokohl AC, Heindl LM.
Ophthalmologe. 2019 Apr;116(4):313-323. doi: 10.1007/s00347-019-0861-y.
Racemose hemangioma of the iris.
López-Herrero F, de Las Morenas-Iglesias J, Franco-Ruedas C, Espiñeira-Periñán A, Sánchez-Vicente JL.
J Fr Ophtalmol. 2021 Mar;44(3):463-464. doi: 10.1016/j.jfo.2020.04.049. Epub 2020 Dec 15.
A distorted pupil could be caused by an iris melanoma.
Lazar D, Kiilgaard JF, Søndergaard AP, Faber C.
Ugeskr Laeger. 2023 May 1;185(18):V12220787.
[Diagnosis and Therapy of Iris Lesions].
Mor JM, Koch KR, Heindl LM.
Klin Monbl Augenheilkd. 2017 Dec;234(12):1541-1554. doi: 10.1055/s-0043-120093. Epub 2017 Nov 20.
Primary iris leiomyoma.
Yeaney GA, Platt S, Singh AD.
Surv Ophthalmol. 2017 May-Jun;62(3):366-370. doi: 10.1016/j.survophthal.2016.11.007. Epub 2016 Nov 24.
Iris Colour and the Risk of Developing Uveal Melanoma.
Houtzagers LE, Wierenga APA, Ruys AAM, Luyten GPM, Jager MJ.
Int J Mol Sci. 2020 Sep 28;21(19):7172. doi: 10.3390/ijms21197172.
Spontaneous Regression of Presumed Iris Melanocytoma.
Azarcon CP, Wells JR.
Ophthalmology. 2022 Jun;129(6):660. doi: 10.1016/j.ophtha.2021.11.020.
Anterior Segment OCTA of Melanocytic Lesions of the Conjunctiva and Iris.
Brouwer NJ, Marinkovic M, Bleeker JC, Luyten GPM, Jager MJ.
Am J Ophthalmol. 2021 Feb;222:137-147. doi: 10.1016/j.ajo.2020.09.009. Epub 2020 Sep 12.
Iris melanoma: Review of clinical features, risks, management, and outcomes.
Cherkas E, Kalafatis NE, Marous MR, Shields CL.
Clin Dermatol. 2024 Jan-Feb;42(1):62-70. doi: 10.1016/j.clindermatol.2023.10.009. Epub 2023 Oct 21.
